Cargando…

Intestinal injury and gut permeability in sickle cell disease

BACKGROUND: Due to recurrent hypoxia-reperfusion injury induced by vaso-occlusive crises (VOC), patients with sickle cell disease (SCD) may have intestinal injury and increased permeability. These may explain the qualitative and quantitative neutrophil abnormalities observed in these patients. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Dibyendu, Methe, Barbara, Amar, Salomon, Morris, Alison, Lim, Seah H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543649/
https://www.ncbi.nlm.nih.gov/pubmed/31146745
http://dx.doi.org/10.1186/s12967-019-1938-8
_version_ 1783423121709072384
author Dutta, Dibyendu
Methe, Barbara
Amar, Salomon
Morris, Alison
Lim, Seah H.
author_facet Dutta, Dibyendu
Methe, Barbara
Amar, Salomon
Morris, Alison
Lim, Seah H.
author_sort Dutta, Dibyendu
collection PubMed
description BACKGROUND: Due to recurrent hypoxia-reperfusion injury induced by vaso-occlusive crises (VOC), patients with sickle cell disease (SCD) may have intestinal injury and increased permeability. These may explain the qualitative and quantitative neutrophil abnormalities observed in these patients. METHODS: Serum intestinal fatty-acid binding protein (iFABP), lipopolysaccharides (LPS), and CD62L were measured by ELISA. Multicolor flow cytometry was used to measure circulating aged neutrophils. RESULTS: Compared to controls, SCD individuals had higher iFABP (median: 1.38 ng/ml vs 0.81 ng/ml; p = 0.04) and LPS (median: 2.15 μg/ml vs 0.69 μg/ml; p = 0.03), indicating intestinal injury and increased intestinal bacterial translocation into the systemic circulation. They also had higher soluble CD62L (median: 1.38 μg/ml vs 1.11 μg/ml; p = 0.04). Among SCD individuals, soluble CD62L correlated positively with circulating aged neutrophils (R = 0.7, p = 0.03) and LPS (R = 0.66, p = 0.027). Surprisingly, serum iFABP in SCD correlated negatively with both LPS (R = − 0.7, p = 0.02) and soluble CD62L (R = − 0.56, p = 0.08). CONCLUSIONS: Since LPS translocation across the intestinal barrier may be due to increases in the intestinal bacterial density, gut permeability, or both, the negative correlations between iFABP and LPS, and CD62L raise the possibility that any damage-associated molecular patterns induced by intestinal injury may modulate the degree of bacterial translocation. Our results provide the first evidence of the presence of intestinal injury and increased gut permeability in SCD.
format Online
Article
Text
id pubmed-6543649
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65436492019-06-04 Intestinal injury and gut permeability in sickle cell disease Dutta, Dibyendu Methe, Barbara Amar, Salomon Morris, Alison Lim, Seah H. J Transl Med Research BACKGROUND: Due to recurrent hypoxia-reperfusion injury induced by vaso-occlusive crises (VOC), patients with sickle cell disease (SCD) may have intestinal injury and increased permeability. These may explain the qualitative and quantitative neutrophil abnormalities observed in these patients. METHODS: Serum intestinal fatty-acid binding protein (iFABP), lipopolysaccharides (LPS), and CD62L were measured by ELISA. Multicolor flow cytometry was used to measure circulating aged neutrophils. RESULTS: Compared to controls, SCD individuals had higher iFABP (median: 1.38 ng/ml vs 0.81 ng/ml; p = 0.04) and LPS (median: 2.15 μg/ml vs 0.69 μg/ml; p = 0.03), indicating intestinal injury and increased intestinal bacterial translocation into the systemic circulation. They also had higher soluble CD62L (median: 1.38 μg/ml vs 1.11 μg/ml; p = 0.04). Among SCD individuals, soluble CD62L correlated positively with circulating aged neutrophils (R = 0.7, p = 0.03) and LPS (R = 0.66, p = 0.027). Surprisingly, serum iFABP in SCD correlated negatively with both LPS (R = − 0.7, p = 0.02) and soluble CD62L (R = − 0.56, p = 0.08). CONCLUSIONS: Since LPS translocation across the intestinal barrier may be due to increases in the intestinal bacterial density, gut permeability, or both, the negative correlations between iFABP and LPS, and CD62L raise the possibility that any damage-associated molecular patterns induced by intestinal injury may modulate the degree of bacterial translocation. Our results provide the first evidence of the presence of intestinal injury and increased gut permeability in SCD. BioMed Central 2019-05-30 /pmc/articles/PMC6543649/ /pubmed/31146745 http://dx.doi.org/10.1186/s12967-019-1938-8 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Dutta, Dibyendu
Methe, Barbara
Amar, Salomon
Morris, Alison
Lim, Seah H.
Intestinal injury and gut permeability in sickle cell disease
title Intestinal injury and gut permeability in sickle cell disease
title_full Intestinal injury and gut permeability in sickle cell disease
title_fullStr Intestinal injury and gut permeability in sickle cell disease
title_full_unstemmed Intestinal injury and gut permeability in sickle cell disease
title_short Intestinal injury and gut permeability in sickle cell disease
title_sort intestinal injury and gut permeability in sickle cell disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543649/
https://www.ncbi.nlm.nih.gov/pubmed/31146745
http://dx.doi.org/10.1186/s12967-019-1938-8
work_keys_str_mv AT duttadibyendu intestinalinjuryandgutpermeabilityinsicklecelldisease
AT methebarbara intestinalinjuryandgutpermeabilityinsicklecelldisease
AT amarsalomon intestinalinjuryandgutpermeabilityinsicklecelldisease
AT morrisalison intestinalinjuryandgutpermeabilityinsicklecelldisease
AT limseahh intestinalinjuryandgutpermeabilityinsicklecelldisease